However, whether CEACAM1-S could assist in conformational stabilization of IL-2 binding to the IL-2 receptor, or whether CEACAM1-ligation by soluble CEACAMs or antibodies could potentially support Treg expansion and enhance their suppressive function in autoimmune liver diseases, remains to be demonstrated. Here, IL2 is linked to autoimmune hepatitis.